Market Overview - The market has been consolidating around the 3500-point level, with a slight increase of 13 points today, indicating a relatively strong overall trend [1] - The central bank has been actively injecting liquidity into the market through a continuous net injection of 7-day reverse repos for three consecutive days, suggesting a supportive funding environment [1] Investment Opportunities - Two sectors showing strong performance today are optical modules and printed circuit boards (PCBs), which are expected to remain active in the technology field [2] - The military and pharmaceutical sectors also demonstrated strong activity, with military equipment showing promising performance as earnings reports approach [2] - The pharmaceutical sector, particularly innovative drugs, has been a major driver this month, supported by new standards and batch procurement policies [3] Sector Analysis - The technology sector, including components and innovative drugs, is highlighted as a key area for investment, while also monitoring the potential recovery in real estate and other sectors like steel and energy metals [3] - Caution is advised against chasing small-cap stocks, as they tend to experience rapid price fluctuations [3]

证券代码：688350 证券简称：富淼科技 公告编号：2025-047 转债代码：118029 转债简称：富淼转债 江苏富淼科技股份有限公司 关于持股5%以上股东协议转让股份暨权益变动、自 愿披露签订战略合作协议的公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责 任。 重要内容提示： 一、本次权益变动的基本情况 公司收到持股5%以上股东飞翔股份的通知，飞翔股份于2025年7月17日与上 海耕瑞签署了《关于江苏富淼科技股份有限公司之股份转让协议》。飞翔股份 拟通过协议转让的方式将其持有的6,107,600股无限售流通股份，以16.38元/股 的价格（参考转让协议签署日前一交易日收盘价确定，不低于前一交易日收盘 价的80%）转让给上海耕瑞，转让股份占公司总股本的5.00%。 本次协议转让各方之间不存在关联关系，本次协议转让不触及要约收购， 不会使公司控股股东、实际控制人发生变化。 本次权益变动前后，交易各方持有富淼科技股份的情况如下： 本次权益变动前 本次权益变动后 ? 江苏富淼科技股份有限公司（以下简称"公司"或"富淼 ...

《科创板日报》17日讯，富淼科技(688350.SH)公告称，股东江苏飞翔化工股份有限公司（简称"飞翔股 份"）于7月17日与上海耕瑞资产管理有限公司（代表"耕瑞泓晟1号私募证券基金"）（简称"上海耕 瑞"）签署了《关于江苏富淼科技股份有限公司之股份转让协议》。飞翔股份拟通过协议转让方式将其 持有的610.76万股无限售流通股份，以16.38元/股的价格转让给上海耕瑞，转让股份占公司总股本的 5%。泓晟1号基金之唯一出资人为庞超，庞超系张家港市新沪毛纺有限公司（简称"新沪毛纺"）实际控 制人。公司与新沪毛纺于7月17日完成签订《战略合作协议》。双方拟在纺织印染产业链的全水处理环 节，积极推进技术研发合作与协同市场开拓，结成深度战略合作伙伴关系。 富淼科技：与新沪毛纺签订战略合作协议 ...

天赐材料（002709） 广州天赐高新材料股份有限公司 关于召开 2025 年第二次临时股东大会的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 广州天赐高新材料股份有限公司（以下简称"公司"）2025年7月4日召开的第 六届董事会第三十三次会议审议通过了《关于召开2025年第二次临时股东大会的 议案》，决定于2025年7月23日（星期三）召开2025年第二次临时股东大会，具体 内容详见公司于2025年7月8日在巨潮资讯网（http://www.cninfo.com.cn）披露的 《关于召开2025年第二次临时股东大会通知的公告》 （公告编号：2025-079）。现 将召开本次股东大会的有关安排公告如下： 一、召开会议的基本情况 和国公司法》《上市公司股东大会规则》等法律、法规、规范性文件及《公司章 程》的相关规定。 证券代码：002709 证券简称：天赐材料 公告编号：2025-083 转债代码：127073 转债简称：天赐转债 （2）网络投票时间为： 通过深圳证券交易所交易系统进行网络投票的具体时间为：2025 年 7 月 23 日上午 9:1 ...

Core Viewpoint - Shanghai Jinhua Adhesive New Materials Co., Ltd. is proceeding with the cancellation of certain stock options and the repurchase of restricted stocks as part of its 2024 incentive plan, following necessary approvals and legal compliance [1][4][11]. Group 1: Approval and Authorization - The 2024 incentive plan, including the cancellation and repurchase of stocks, has been approved by the company's board and relevant committees, with necessary disclosures made [4][6][11]. - The board's authorization allows the company to execute the cancellation and repurchase without needing further shareholder approval [7][11]. Group 2: Cancellation and Repurchase Details - The cancellation involves 30,000 stock options and the repurchase of 32,000 restricted stocks due to the disqualification of two incentive recipients [8][9]. - The repurchase price for the restricted stocks has been adjusted from 4.24 yuan to 4.15 yuan per share, with a total repurchase cost of 132,800 yuan plus interest [9][10]. Group 3: Impact on Share Structure - Following the cancellation and repurchase, the number of restricted shares will decrease from 30,843,372 to 30,811,372, while the total share count will drop from 289,634,661 to 289,602,661 [10][11]. - The changes in share structure will be finalized after the completion of the repurchase and necessary regulatory filings [10][11].

Group 1: Company Overview and R&D - The company’s R&D expenses for 2024 are expected to increase by 10% year-on-year, focusing on the development of raw materials and formulations, as well as process optimization and technological innovation for mature products like vitamins [1] - The company has officially started selling para-hydroxyphenol in the PEEK field and is actively promoting its products, having completed sample submissions to major domestic PEEK manufacturers, currently in various validation stages [1] Group 2: Product Registration and Market Activities - The company holds registration certificates for two products: Fumaric Acid Bisoprolol Tablets and Lacosamide Injection, with the former having commenced market promotion and industrialization in 2024 [1] - There are currently no plans for stock incentive programs or share buybacks, although the company previously repurchased shares in 2019 and conducted a restricted stock incentive plan in 2015, along with the first employee stock ownership plan launched in 2021 [2] Group 3: Inventory and Capital Expenditure - The company’s large ending inventory balance is attributed to its diverse business segments, including vitamins, flavors, raw materials, leather chemicals, and chromium salts, consisting mainly of raw materials, work-in-progress, and finished products to meet varying customer demands [2] - Future capital expenditures will primarily focus on new project construction, such as a 600-ton iodinated contrast agent raw material project, and technological upgrades to existing projects aimed at cost reduction, efficiency enhancement, and improved safety and environmental control [2] Group 4: Risk Management - The company has not engaged in hedging activities and currently sees no demand for such services [2]

历史数据显示，近三个月内招商证券深圳红岭路营业部与中泰证券广东分公司上榜后个股三日上涨概率 均达50%，而中国国际金融北京建国门外大街营业部对应概率仅为26.53%。该股近三个月累计上榜四 次，期间股价波动幅度显著。 卖方阵营中，国泰海通证券上海松江营业部以5183.87万元成为最大空头，中国国际金融北京建国门外 大街营业部以1762.16万元位列第三。开源证券西安西大街营业部及前述瑞银证券营业部分别卖出 1606.81万元、1493.27万元，五家营业部合计抛售1.31亿元。 2025年7月17日盘后数据显示，联环药业因换手率超20%登上龙虎榜。买入前五席位中，国泰海通证券 总部以4277.89万元居首，招商证券深圳红岭路营业部与瑞银证券上海浦东营业部分别以1671.87万元、 1638.24万元紧随其后。中国国际金融上海分公司及中泰证券广东分公司分别贡献1482.83万元、1395.01 万元，五家营业部合计买入金额达1.05亿元。 值得关注的是，国泰海通证券总部与瑞银证券上海浦东营业部同时现身买卖双向榜单。前者在买入 4277.89万元的同时，通过另一席位卖出3010.68万元；后者则在买入1638.2 ...

Debt Issuance - Heilongjiang Province plans to issue special bonds totaling 8.9 billion yuan, with a 10-year maturity, to fund government investment projects[3] - In the first half of 2025, Heilongjiang's total government bond issuance reached 104.1 billion yuan, ranking it at a medium level nationally[41] - In June 2025, the total bond issuance was 27.4 billion yuan, including 23.57 billion yuan in general bonds and 3.8 billion yuan in special bonds[41] Market Performance - Heilongjiang sector index increased by 2.59% from July 1 to July 11, 2025, reaching a new high for the year[21] - The top-performing stocks included Hatou Co. (+15.19%), Huadian Energy (+14.53%), and Xiangcai Co. (+13.96%) during the same period[25] - The worst-performing stock was Guangzhi Technology, which fell by 10.53%[26] Economic Indicators - The manufacturing PMI for June 2025 was reported at 49.7%, indicating a slight improvement from the previous month[27] - The consumer price index (CPI) rose by 0.1% year-on-year in June, ending a four-month decline, driven by a rebound in industrial consumer goods prices[31] - The producer price index (PPI) showed an expanded year-on-year decline of 0.3 percentage points in June, reflecting ongoing adjustments in supply and demand dynamics[32]

苏州世名科技股份有限公司（以下简称"公司"或"世名科技"）于 2025 年 5 月 29 日召开第五届董事会第十四次会议审议通过了《关于对外投资设立合资公 司的议案》，同意公司与厦门 TCL 科技产业投资有限公司（以下简称"TCL 产 投"）共同出资设立合资公司，并与 TCL 产投签订《合资协议》。合资公司注 册资本 2,000 万元人民币，其中公司以自有资金出资 1,320 万元，占合资公司注 册资本的 66%；TCL 产投出资 680 万元，占合资公司注册资本的 34%，合资公 司成立后将纳入公司合并报表范围。具体内容详见公司于巨潮资讯网 （http://www.cninfo.com.cn）上披露的公司《关于对外投资设立合资公司的公告》 （公告编号：2025-023）。 二、进展情况介绍 近日，公司已完成合资公司的工商注册登记手续，并取得常熟市数据局下发 的《营业执照》，相关信息如下： 证券代码：300522 证券简称：世名科技 公告编号：2025-030 苏州世名科技股份有限公司 关于投资设立合资公司完成注册登记并取得营业执照的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记 ...

策略报告| 投资策略 策略专题 | 如何定位"市场化反内卷"? | 作者 | | | --- | --- | --- | | 吴鼎达 | | 分析师 | | SAC 执业证书编号:S1110524030001 | | | | wukaida@tfzq.com | | | | 核心结论: 孙希民 | | 分析师 | | SAC 执业证书编号:S1110524110002 | | | | 我们认为，本轮反内卷逻辑和供给侧改革有所不同，本轮反内卷更侧重于成本 sunximin@tfzq.com | | | | 调查和价格监测,治理企业低价无序竞争。提价本身需要行业的供给格局配合， 日消零 | | 联系人 | | 我们从"内卷"程度、产能出清程度、产能出清弹性三个方面讨论哪些行业更 wangchengrui@tfzq.com | | | | 具备基本面率先改善的潜质。以 CAPEX、毛利率和存货的历史分位数水平衡量 | | | | 行业的"内卷程度",以上述三个指标是否发生趋势的拐点判断行业出清是否启 相关报告 | | | | 动，目的是筛选本身已经在去产能、出清的行业。 | | | | 1《投资策略:"对等关税"再 ...